• Good governance for medicines initiatives: Exploring lessons learned 

      Kohler, Jillian Clare; Ovtcharenko, Natalia (U4 Issue 2013:3, Research report, 2013-05-13)
      Corruption in the pharmaceutical system results in wasted resources, limited access to health services and reduced health gains. In this U4 Issue paper, we examine select global initiatives in the area of good governance ...
    • Using Corruption Risk Assessments for REDD+: An Introduction for Practitioners 

      Williams, Aled (U4 Issue 2014:1, Research report, 2014-01-03)
      Corruption Risk Assessments (CRAs) are both an analytic and due diligence exercise to identify issues associated with, contributing to, or otherwise facilitating corruption in a particular setting. An area where improved ...